AMGN News 115.46 Amgen Inc (AMGN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amgen Inc (AMGN) 115.46 $AMGN

Final Glance: Biotechnology companies
AP - Thu Apr 17, 5:01PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Emergent BioSolutions Gains on Trial News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 4:10PM CDT
Emergent BioSolutions is looking to expand BioThrax's label.

Amgen Announces Webcast of 2014 First Quarter Financial Results
PR Newswire - Thu Apr 17, 3:05PM CDT
Amgen (NASDAQ: AMGN) today announced that it will report its first quarter financial results on Tuesday, April 22, 2014, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:15 p.m. PDT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Early Glance: Biotechnology companies
AP - Thu Apr 17, 10:31AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 17, 8:30AM CDT
Biotech stocks have taken a punishing nose-dive over the past month as investors step aside following significant gains. However, the current share slide is likely more a result of emotion than any long-term changes at drug developer heavyweights ...

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings
at The Street - Thu Apr 17, 8:18AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 3:10PM CDT
Dynavax Technologies commenced a new phase III study (HBV-23) on its hepatitis B vaccine candidate, Heplisav-B

Midday Glance: Biotechnology companies
AP - Wed Apr 16, 12:30PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Google, Disney, Paramount Execs Join Pepperdine University's Talent Management Symposium, April 25
Business Wire - Wed Apr 16, 10:00AM CDT
Human resources and learning officers from leading California employers are among the expert speakers added to the Talent Management Symposium: Leveraging Human Capital program on Friday, April 25, 2014, announced Pepperdine University's Graziadio School of Business and Management. Human resources professionals, organization development leaders and functional managers and supervisors will hear speakers from both the business and the academic worlds discuss the art of attracting, developing, deploying and retaining talent to achieve strategic objectives and meet future business needs.

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 16, 9:07AM CDT
The selloff in the biotech sector continued with overall sentiment remaining bearish.

'Fast Money' Recap: Impressed by Yahoo!
at The Street - Wed Apr 16, 4:00AM CDT
The trading panel discussed Yahoo!'s earnings and Alibaba's IPO.

RBCC Bioprinting Partner Expands Brand Awareness Campaign
Business Wire - Wed Apr 16, 3:28AM CDT
Rainbow Coral Corp.'s (OTCBB: RBCC) 3D bioprinting partner, Nano3D Biosciences (n3D), has presented their groundbreaking technology at two high-profile events in recent weeks as part of a campaign to build brand awareness around the revolutionary BiO Assay system.

Repros Completes Enrollment for Androxal Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 5:15PM CDT
Repros Therapeutics announced it has completed enrollment for one of the two head-to-head studies on its secondary hypogonadism candidate, Androxal.

Encouraging Results from Lexicon Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 4:20PM CDT
Lexicon announced encouraging results from a phase II study on LX4211.

FDA Nod for Merck's Grastek - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 4:11PM CDT
Merck announced that the FDA has approved Grastek, a timothy grass pollen allergen extract.

Alimera/pSivida Seek FDA Approval for Iluvien - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 3:45PM CDT
The FDA accepted Alimera Sciences' re-submitted NDA for Iluvien. PDUFA date for Iluvien is now set for Sep 26, 2014.

Another Earnings Beat from J&J, View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 1:17PM CDT
J&J's earnings streak continues with the company reporting strong first quarter results and raising its guidance for the year.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zunyi’s History Tour Carries China’s Story Overseas

Updated Category News Views 125

China’s national story does not travel overseas by accident; it gets carried by visitors, monuments, rail lines, rivers and carefully chosen questions. The Zunyi News and Media Center report follows Tayyab, a Pakistani PhD student in aerospace engineering at Peking University, as he heads from Beijing to Zunyi, Guizhou, carrying a copy of Edgar Snow’s Red Star Over...

Continue Reading
Rosengart's Repeat Honor Signals Litigation Bench Depth

Updated Category News Views 134

Hollywood lawsuits rarely stay tucked inside a filing cabinet; they spill into headlines, contracts, careers, and sometimes a company's whole public posture. That is why Mathew S. Rosengart landing on The Hollywood Reporter's Top 25 Legal Troubleshooters list for a second straight year is more than a pleasant plaque for the office wall. It is a reminder that, in media and...

Continue Reading
Leqembi’s Real-World Data Gives BioArctic More Weight

Updated Category News Views 133

A Harder Look at Treatment Staying Power Alzheimer’s drug data rarely arrive without a thicket of caveats, and that is exactly why this Leqembi update deserves a calm read rather than a victory lap. BioArctic’s partner Eisai presented a three-year real-world analysis at CTAD 2026 covering 560 early Alzheimer’s patients across 13 U.S. sites. The headline is striking:...

Continue Reading
IIT Madras Maps 100 Brains in a Serious Science Bet

Updated Category News Views 40

A human brain turned into a navigable cellular map is not a flashy launch-day trinket. It is painstaking infrastructure, the kind that can sit quietly for years before researchers figure out what it truly unlocks. That is why the Sudha Gopalakrishnan Brain Centre mission at IIT Madras deserves a serious look rather than the usual chest-thumping over a big scientific...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 118

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 93

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
Stitch AI Targets Banking’s Hardest Automation Gap

Updated Category News Views 109

The flashy chatbot stuff is cheap; banking permission to act is not. That is why Stitch AI’s launch deserves more attention than another vendor slapping “agentic” on a slide deck and calling it transformation. Banks do not need a machine to summarize a policy document while everyone applauds the demo. They need technology that can touch real workflows without...

Continue Reading
SHIFTAIon Puts Governance at Center of AI Migration

Updated Category News Views 69

Legacy code is where grand AI promises usually go to get mugged by reality. ACL Digital’s new SHIFTAIon platform is taking a sensible swing at that ugly problem: not merely generating code faster, but putting discovery, architecture decisions, testing, security checks, reviewer signoffs, and reporting into one controlled modernization process. That distinction matters....

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 194

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 103

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading

Top 5 Most Recently Viewed Articles

HERE Technologies Celebrates Sustainability Efforts in 2024 Report

Updated Category News Views 986

HERE Technologies Unveils Annual Sustainability Report for 2024 HERE Technologies, the frontrunner in location data and technology, has rolled out its fifth annual Sustainability Report, which spotlights the advances made in Environmental, Social, and Governance (ESG) initiatives. This year, the report highlights HERE's integral part in facilitating global sustainability...

Continue Reading
Rocket Lab's HASTE Launch Enhances National Defense Initiatives

Updated Category News Views 195

Rocket Lab's Successful HASTE Launch Elevates National Defense Rocket Lab Corporation (Nasdaq: RKLB) has made waves in the aerospace sector with its latest achievement, a successful launch of the HASTE mission. This mission has great importance for not only Rocket Lab as a prominent provider of launch services and space systems but also for national security. This launch,...

Continue Reading
Jabil's Stock Surge Driven by New Warrant Issuance

Updated Category News Views 197

Jabil Inc. Shares Experience a Positive Shift Jabil Inc. (NYSE: JBL) is making headlines as its stock sees an upward movement, particularly notable on a recent Friday. This surge is primarily attributed to the announcement regarding a warrant issuance to Amazon.Com, Inc. (NASDAQ: AMZN) NV Investment Holdings. This strategic move allows Amazon to potentially acquire up to...

Continue Reading
Understanding Net Asset Values for Middlefield Income PCC

Updated Category News Views 152

Exploring Net Asset Values of Middlefield Canadian Income PCC The Middlefield Canadian Income PCC holds a distinct position in the investment landscape. Its net asset value (NAV) reflects the value of the company's assets minus its liabilities, providing a clear picture of its financial health. Recent Measurements of Net Asset Value As of a recent assessment, the...

Continue Reading
Innovative Fundraising at The Folded Flag Foundation Gala

Updated Category News Views 112

A Night to Remember: The Folded Flag Foundation Gala The Folded Flag Foundation recently held its annual gala, and the community truly came together, raising an impressive $1.1 million. This significant amount will go toward supporting Gold Star families. This event has gained a reputation for honoring the legacies of America's fallen service members, making it an...

Continue Reading